指南与共识心脑血管急症重症综合管理与镇静镇痛

重症成人脑出血神经预后判断指南

Guidelines for Neuroprognostication in Critically Ill Adults with Intracerebral Hemorrhage.
指南 / 共识 · Neurocrit Care · 2023-11-03
一句话结论指南建议脑出血后至少48–72小时内不进行神经预后判断(最严重患者除外),且不单独依据任一临床变量或评分向家属咨询3个月后功能结局或30天死亡风险。

本指南由神经重症领域制定,采用GRADE方法学及PICOTS问题,对6个候选临床变量和2个评分量表(原始ICH评分与最大治疗ICH评分)进行系统综述,共筛选10751篇文献,最终纳入347篇。良好实践声明建议:除最严重患者外,入住ICU后至少48–72小时内不进行神经预后判断;了解患者最看重的结局;向患者及代理人说明神经功能恢复可能历经不同时长。专家组未建议任一临床变量或单一评分量表可单独可靠用于咨询3个月及以后功能结局或30天死亡。临床医生应避免仅基于任一临床变量或已发表评分产生锚定偏倚。

要点

  • 除最严重患者外,脑出血患者入住ICU后至少48–72小时内应暂缓神经预后判断。
  • 专家组未建议任一临床变量或单一评分量表可单独可靠用于咨询3个月及以后功能结局或30天死亡。
  • 预后咨询前应了解患者最看重的结局,并向患者及代理人说明神经功能恢复可能历经不同时长。
  • 临床医生判断预后时应避免仅基于任一临床变量或已发表临床评分量表的锚定偏倚。

适用人群与场景

  • 重症成人脑出血患者,场景为ICU入院后神经预后判断与向患者及代理人咨询。

处置流程与药物剂量

  • 良好实践声明:除最严重患者外,入住ICU后至少48–72小时内暂缓神经预后判断。
  • 良好实践声明:预后判断前应了解患者最看重的结局。
  • 良好实践声明:向患者及代理人说明最终神经功能恢复可能历经不同时长。
  • 专家组未建议任一临床变量或单一临床评分量表可单独可靠用于咨询3个月及以后功能结局或30天死亡。

研究设计与关键结果

  • 采用GRADE方法学及PICOTS问题完成叙述性系统综述,筛选10751篇文献,纳入347篇符合标准文献。
  • 选定6个候选临床变量和2个临床评分量表(原始ICH评分与最大治疗ICH评分)用于制定推荐。
  • 许多临床变量和评分量表与脑出血不良结局相关,但专家组未建议任一临床变量或单一评分量表可单独可靠用于咨询3个月及以后功能结局或30天死亡。

证据类型、等级与局限

  • 证据类型:指南(系统综述基于GRADE方法学)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 临床医生为脑出血患者判断预后时,应避免仅基于任一临床变量或已发表临床评分量表产生锚定偏倚(作者建议)。
  • 除最严重患者外,入住ICU后至少48–72小时内暂缓神经预后判断(良好实践声明)。
  • 向患者及代理人咨询时,应说明神经功能恢复可能历经不同时长,并了解患者最看重的结局(良好实践声明)。
  • 不应将任一临床变量或单一评分量表作为单独可靠的咨询依据用于3个月及以后功能结局或30天死亡(专家组未建议)。

指南或共识出处

  • 指南名称:Guidelines for Neuroprognostication in Critically Ill Adults with Intracerebral Hemorrhage;发布机构:Neurocrit Care;年份:原文未写明。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The objective of this document is to provide recommendations on the formal reliability of major clinical predictors often associated with intracerebral hemorrhage (ICH) neuroprognostication.

METHODS: A narrative systematic review was completed using the Grading of Recommendations Assessment, Development, and Evaluation methodology and the Population, Intervention, Comparator, Outcome, Timing, Setting questions. Predictors, which included both individual clinical variables and prediction models, were selected based on clinical relevance and attention in the literature. Following construction of the evidence profile and summary of findings, recommendations were based on Grading of Recommendations Assessment, Development, and Evaluation criteria. Good practice statements addressed essential principles of neuroprognostication that could not be framed in the Population, Intervention, Comparator, Outcome, Timing, Setting format.

RESULTS: Six candidate clinical variables and two clinical grading scales (the original ICH score and maximally treated ICH score) were selected for recommendation creation. A total of 347 articles out of 10,751 articles screened met our eligibility criteria. Consensus statements of good practice included deferring neuroprognostication-aside from the most clinically devastated patients-for at least the first 48-72 h of intensive care unit admission; understanding what outcomes would have been most valued by the patient; and counseling of patients and surrogates whose ultimate neurological recovery may occur over a variable period of time. Although many clinical variables and grading scales are associated with ICH poor outcome, no clinical variable alone or sole clinical grading scale was suggested by the panel as currently being reliable by itself for use in counseling patients with ICH and their surrogates, regarding functional outcome at 3 months and beyond or 30-day mortality.

CONCLUSIONS: These guidelines provide recommendations on the formal reliability of predictors of poor outcome in the context of counseling patients with ICH and surrogates and suggest broad principles of neuroprognostication. Clinicians formulating their judgments of prognosis for patients with ICH should avoid anchoring bias based solely on any one clinical variable or published clinical grading scale.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Hwang DY, Kim KS, Muehlschlegel S, et al. Guidelines for Neuroprognostication in Critically Ill Adults with Intracerebral Hemorrhage. Neurocrit Care. 2023. PMID: 37923968. doi:10.1007/s12028-023-01854-7

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。